Impact of Statin Use on Survival in Patients Undergoing Resection for Early-Stage Pancreatic Cancer

Abstract

The effects of statins varied by agent and dose. Active use of moderate-high-dose simvastatin at baseline was associated with improved overall and disease-free survival among patients undergoing resection for pancreatic cancer.